Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mei Sheng Duh

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Taher AT, Origa R, Perrotta S, Kouraklis A, Belhoul K, Huang V, Han J, Bruederle A, Bobbili P, Duh MS, Porter JB. Influence of patient-reported outcomes on the treatment effect of deferasirox film-coated and dispersible tablet formulations in the ECLIPSE trial: A post hoc mediation analysis. Am J Hematol. 2019 Apr; 94(4):E96-E99. PMID: 30663129.
    Citations:    Fields:    
  2. Dasari A, Bergsland EK, Benson AB, Cai B, Huynh L, Totev T, Shea J, Duh MS, Neary MP, Dagohoy CG, Shih BE, Maurer VE, Chan J, Kulke MH. Treatment Patterns and Clinical Outcomes in Advanced Lung Neuroendocrine Tumors in Real-World Settings: A Multicenter Retrospective Chart Review Study. Oncologist. 2019 Jan 04. PMID: 30610008.
    Citations:    Fields:    
  3. Appukkuttan S, Duchesneau E, Zichlin ML, Bhak RH, Yaldo A, Gharibo M, Babajanyan S, Duh MS. A Budget Impact Analysis of the Introduction of Copanlisib for Treatment of Relapsed Follicular Lymphoma in the United States. J Manag Care Spec Pharm. 2019 Jan 04; 1-12. PMID: 30608008.
    Citations:    Fields:    
  4. Kulke MH, Benson AB, Dasari A, Huynh L, Cai B, Totev T, Roesner N, Duh MS, Neary MP, Maurer VE, Shih BE, Dagohoy CG, Chan J, Bergsland EK. Real-World Treatment Patterns and Clinical Outcomes in Advanced Gastrointestinal Neuroendocrine Tumors (GI NET): A Multicenter Retrospective Chart Review Study. Oncologist. 2019 Jan 03. PMID: 30606883.
    Citations:    Fields:    
  5. Tarhini A, Ghate SR, Ionescu-Ittu R, Manceur AM, Ndife B, Jacques P, Laliberté F, Nakasato A, Burne R, Duh MS. Postsurgical treatment landscape and economic burden of locoregional and distant recurrence in patients with operable nonmetastatic melanoma. Melanoma Res. 2018 12; 28(6):618-628. PMID: 30216199.
    Citations:    Fields:    
  6. Khelif A, Saleh MN, Salama A, Portella MDSO, Duh MS, Ivanova J, Grotzinger K, Roy AN, Bussel JB. Changes in health-related quality of life with long-term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND study. Am J Hematol. 2019 Feb; 94(2):200-208. PMID: 30417939.
    Citations:    Fields:    
  7. Zonnenberg BA, Neary MP, Duh MS, Ionescu-Ittu R, Fortier J, Vekeman F. Observational study of characteristics and clinical outcomes of Dutch patients with tuberous sclerosis complex and renal angiomyolipoma treated with everolimus. PLoS One. 2018; 13(11):e0204646. PMID: 30439947.
    Citations:    Fields:    
  8. Laliberté F, Dea K, Duh MS, Kahler KH, Rolli M, Lefebvre P. Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy. Menopause. 2018 Nov; 25(11):1297-1305. PMID: 30358726.
    Citations:    Fields:    
  9. Halperin DM, Huynh L, Beaumont JL, Cai B, Totev T, Bhak RH, Duh MS, Neary MP, Cella D. Impact of carcinoid syndrome symptoms and long-term use of somatostatin analogs on quality of life in patients with carcinoid syndrome: A survey study. Medicine (Baltimore). 2018 Nov; 97(47):e13390. PMID: 30461659.
    Citations:    Fields:    Translation:Humans
  10. Wysham CH, Lefebvre P, Pilon D, Lafeuille MH, Emond B, Kamstra R, Pfeifer M, Duh MS, Ingham M. An investigation into the durability of glycemic control in patients with type II diabetes initiated on canagliflozin or sitagliptin: A real-world analysis of electronic medical records. J Diabetes Complications. 2019 Feb; 33(2):140-147. PMID: 30554838.
    Citations:    Fields:    
  11. Ortega H, Llanos JP, Lafeuille MH, Duh MS, Germain G, Lejeune D, Sama S, Bell C, Hahn B. Effects of systemic corticosteroids on blood eosinophil counts in asthma: real-world data. J Asthma. 2018 Oct 16; 1-8. PMID: 30130418.
    Citations:    Fields:    
  12. Tarhini A, Ghate S, Ionescu-Ittu R, Shi S, Nakasato A, Ndife B, Laliberté F, Burne R, Duh MS. Stage III melanoma incidence and impact of transitioning to the 8th AJCC staging system: a US population-based study. Future Oncol. 2019 Feb; 15(4):359-370. PMID: 30317881.
    Citations:    Fields:    
  13. Ghate S, Ionescu-Ittu R, Burne R, Ndife B, Laliberté F, Nakasato A, Duh MS. Patterns of treatment and BRAF testing with immune checkpoint inhibitors and targeted therapy in patients with metastatic melanoma presumed to be BRAF positive. Melanoma Res. 2018 Oct 09. PMID: 30247203.
    Citations:    Fields:    
  14. Llanos JP, Ortega H, Germain G, Duh MS, Lafeuille MH, Tiggelaar S, Bell CF, Hahn B. Health characteristics of patients with asthma, COPD and asthma-COPD overlap in the NHANES database. Int J Chron Obstruct Pulmon Dis. 2018; 13:2859-2868. PMID: 30254433.
    Citations:    Fields:    Translation:Humans
  15. Oh WK, Cheng WY, Miao R, Vekeman F, Gauthier-Loiselle M, Duh MS, Drea E, Szatrowski TP. Real-world outcomes in patients with metastatic castration-resistant prostate cancer receiving second-line chemotherapy versus an alternative androgen receptor-targeted agent (ARTA) following early progression on a first-line ARTA in a US community oncology setting. Urol Oncol. 2018 11; 36(11):500.e1-500.e9. PMID: 30201382.
    Citations:    Fields:    Translation:Humans
  16. Vekeman F, Weiss L, Aram J, Ionescu-Ittu R, Moosavi S, Xiao Y, Cheng WY, Bhak RH, Tawadrous M, Capparella MR, Montravers P, Duh MS. Retrospective cohort study comparing the risk of severe hepatotoxicity in hospitalized patients treated with echinocandins for invasive candidiasis in the presence of confounding by indication. BMC Infect Dis. 2018 Aug 29; 18(1):438. PMID: 30157797.
    Citations:    Fields:    Translation:Humans
  17. Young JB, Gauthier-Loiselle M, Bailey RA, Manceur AM, Lefebvre P, Greenberg M, Lafeuille MH, Duh MS, Bookhart B, Wysham CH. Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data. Cardiovasc Diabetol. 2018 08 24; 17(1):118. PMID: 30143045.
    Citations:    Fields:    Translation:HumansPHPublic Health
  18. Ortega H, Llanos JP, Lafeuille MH, Germain G, Duh MS, Bell CF, Sama SR, Hahn B. Burden of disease associated with a COPD eosinophilic phenotype. Int J Chron Obstruct Pulmon Dis. 2018; 13:2425-2433. PMID: 30147308.
    Citations:    Fields:    Translation:HumansCells
  19. Ghate SR, Ionescu-Ittu R, Burne R, Ndife B, Laliberté F, Nakasato A, Duh MS. Healthcare resource utilization in patients with metastatic melanoma receiving first-line therapy with dabrafenib?+?trametinib versus nivolumab or pembrolizumab monotherapy. Curr Med Res Opin. 2018 Dec; 34(12):2169-2176. PMID: 30009647.
    Citations:    Fields:    
  20. Kallenbach L, Shui AM, Cheng WY, Fan T, Hu W, Zichlin ML, Duh MS, Ye F, Levin PA. Predictors and Clinical Outcomes of Treatment Intensification in Patients With Type 2 Diabetes Uncontrolled on Basal Insulin in a Real-World Setting. Endocr Pract. 2018 09; 24(9):805-814. PMID: 29975575.
    Citations:    
  21. Slater J, Chung S, Huynh L, Duh MS, Gorin B, McMicken C, Ziemann A, Isojarvi J. Efficacy of antiepileptic drugs in the adjunctive treatment of refractory partial-onset seizures: Meta-analysis of pivotal trials. Epilepsy Res. 2018 07; 143:120-129. PMID: 29784458.
    Citations:    Fields:    
  22. Ghaswalla PK, Patterson BJ, Cheng WY, Duchesneau E, Macheca M, Duh MS. Hepatitis A, B, and A/B vaccination series completion among US adults: A claims-based analysis. Hum Vaccin Immunother. 2018 Jun 20; 1-6. PMID: 29923789.
    Citations:    Fields:    
  23. Cheng WY, Said Q, Hao Y, Xiao Y, Vekeman F, Bobbili P, Duh MS, Nandal S, Blinder M. Adherence to iron chelation therapy in patients who switched from deferasirox dispersible tablets to deferasirox film-coated tablets. Curr Med Res Opin. 2018 Nov; 34(11):1959-1966. PMID: 29701080.
    Citations:    Fields:    
  24. Walker AM, Schneeweiss S, DerSarkissian M, Duh MS. Removal of ineligible outcome cases reduces confounding. Clin Epidemiol. 2018; 10:575-579. PMID: 29872346.
    Citations:    
  25. Patel AK, Duh MS, Barghout V, Yenikomshian MA, Xiao Y, Wynant W, Tabesh M, Fuchs CS. Real-world Treatment Patterns Among Patients With Colorectal Cancer Treated With Trifluridine/Tipiracil and Regorafenib. Clin Colorectal Cancer. 2018 09; 17(3):e531-e539. PMID: 29803544.
    Citations:    Fields:    
  26. Tanton D, Duh MS, Lafeuille MH, Lefebvre P, Pilon D, Zhdanava M, Emond B, Inman D, Bailey RA. Real-world evaluation of Hba1c, blood pressure, and weight loss among patients with type 2 diabetes mellitus treated with canagliflozin: an analysis of electronic medical records from a network of hospitals in Florida. Curr Med Res Opin. 2018 Jun; 34(6):1099-1115. PMID: 29468896.
    Citations:    Fields:    
  27. Pickard AS, Huynh L, Ivanova JI, Totev T, Graham S, Mühlbacher AC, Roy A, Duh MS. Value of transfusion independence in severe aplastic anemia from patients' perspectives - a discrete choice experiment. J Patient Rep Outcomes. 2017; 2(1):13. PMID: 29757294.
    Citations:    
  28. Jabbour E, DerSarkissian M, Duh MS, McCormick N, Cheng WY, McGarry LJ, Souroutzidis A, Huang H, O'Brien S, Ravandi F, Kantarjian HM. Efficacy of Ponatinib Versus Earlier Generation Tyrosine Kinase Inhibitors for Front-line Treatment of Newly Diagnosed Philadelphia-positive Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk. 2018 04; 18(4):257-265. PMID: 29519619.
    Citations:    Fields:    
  29. Stanford RH, Nag A, Mapel DW, Lee TA, Rosiello R, Schatz M, Vekeman F, Gauthier-Loiselle M, Merrigan JFP, Duh MS. Claims-based risk model for first severe COPD exacerbation. Am J Manag Care. 2018 Feb 01; 24(2):e45-e53. PMID: 29461849.
    Citations:    Fields:    
  30. Ruud Bosch JLH, Vekeman F, Duh MS, Neary M, Magestro M, Fortier J, Karner P, Ionescu-Ittu R, Zonnenberg BA. Factors associated with the number and size of renal angiomyolipomas in sporadic angiomyolipoma (sAML): a study of adult patients with sAML managed in a Dutch tertiary referral center. Int Urol Nephrol. 2018 Mar; 50(3):459-467. PMID: 29333579.
    Citations:    Fields:    Translation:Humans
  31. Yan S, DerSarkissian M, Bhak RH, Lefebvre P, Duh MS, Krishnarajah G. Relationship between patient copayments in Medicare Part D and vaccination claim status for herpes zoster and tetanus-diphtheria-acellular pertussis. Curr Med Res Opin. 2018 Jul; 34(7):1261-1269. PMID: 29231748.
    Citations: 1     Fields:    
  32. Ivanova JI, Saverno KR, Sung J, Duh MS, Zhao C, Cai S, Vekeman F, Peevyhouse A, Dhawan R, Fuchs CS. Real-world treatment patterns and effectiveness among patients with metastatic colorectal cancer treated with ziv-aflibercept in community oncology practices in the USA. Med Oncol. 2017 Nov 04; 34(12):193. PMID: 29103187.
    Citations:    Fields:    Translation:Humans
  33. Oh WK, Miao R, Vekeman F, Sung J, Cheng WY, Gauthier-Loiselle M, Dhawan R, Duh MS. Patient characteristics and overall survival in patients with post-docetaxel metastatic castration-resistant prostate cancer in the community setting. Med Oncol. 2017 Aug 10; 34(9):160. PMID: 28795333.
    Citations: 1     Fields:    Translation:Humans
  34. Krishnarajah G, Kageleiry A, Korves C, Lefebvre P, Duh MS. Public health impact of Rotarix vaccination among commercially insured children in the United States. Vaccine. 2017 09 05; 35(37):5065-5072. PMID: 28778611.
    Citations:    Fields:    Translation:HumansPHPublic Health
  35. Faught E, Laliberté F, Wang Z, Barghout V, Haider B, Lejeune D, Germain G, Choi J, Wagh A, Duh MS. Health care resource utilization before and after perampanel initiation among patients with epilepsy in the United States. Epilepsia. 2017 10; 58(10):1742-1748. PMID: 28741690.
    Citations:    Fields:    Translation:Humans
  36. Mapel D, Laliberté F, Roberts MH, Sama SR, Sundaresan D, Pilon D, Lefebvre P, Duh MS, Patel J. A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy. Int J Chron Obstruct Pulmon Dis. 2017; 12:1825-1836. PMID: 28684905.
    Citations: 1     Fields:    Translation:Humans
  37. Lefebvre P, Muser E, Joshi K, DerSarkissian M, Bhak RH, Duh MS, Shiner B, Young-Xu Y. Impact of Paliperidone Palmitate Versus Oral Atypical Antipsychotics on Health Care Resource Use and Costs in Veterans With Schizophrenia and Comorbid Substance Abuse. Clin Ther. 2017 Jul; 39(7):1380-1395.e4. PMID: 28641996.
    Citations: 1     Fields:    Translation:Humans
  38. Huynh L, Totev T, Vekeman F, Neary MP, Duh MS, Benson AB. Cost reduction from resolution/improvement of carcinoid syndrome symptoms following treatment with above-standard dose of octreotide LAR. J Med Econ. 2017 Sep; 20(9):945-951. PMID: 28562131.
    Citations:    Fields:    Translation:Humans
  39. Oh WK, Miao R, Vekeman F, Sung J, Cheng WY, Gauthier-Loiselle M, Dhawan R, Duh MS. Real-world Characteristics and Outcomes of Patients With Metastatic Castration-resistant Prostate Cancer Receiving Chemotherapy Versus Androgen Receptor-targeted Therapy After Failure of First-line Androgen Receptor-targeted Therapy in the Community Setting. Clin Genitourin Cancer. 2017 Jun 19. PMID: 28729067.
    Citations: 1     Fields:    
  40. Piña-Garza JE, Montouris GD, Vekeman F, Cheng WY, Tuttle E, Giguere-Duval P, Duh MS, Shen V, Saurer TB, Isojarvi J. Assessment of treatment patterns and healthcare costs associated with probable Lennox-Gastaut syndrome. Epilepsy Behav. 2017 08; 73:46-50. PMID: 28609734.
    Citations: 3     Fields:    Translation:Humans
  41. Wysham CH, Lefebvre P, Pilon D, Ingham M, Lafeuille MH, Emond B, Kamstra R, Chow W, Pfeifer M, Duh MS. Quality measure and weight loss assessment in patients with type 2 diabetes mellitus treated with canagliflozin or dipeptidyl peptidase-4 inhibitors. BMC Endocr Disord. 2017 Jun 08; 17(1):32. PMID: 28595617.
    Citations:    Fields:    Translation:Humans
  42. Herring M, Huynh L, Duh MS, Vekeman F, Tiew A, Neary M, Bergsland E. Real-world treatment patterns in advanced pancreatic neuroendocrine tumors in the era of targeted therapy: perspectives from an academic tertiary center and community oncology practices. Med Oncol. 2017 May; 34(5):88. PMID: 28393314.
    Citations:    Fields:    Translation:Humans
  43. Nicolini FE, Basak GW, Kim DW, Olavarria E, Pinilla-Ibarz J, Apperley JF, Hughes T, Niederwieser D, Mauro MJ, Chuah C, Hochhaus A, Martinelli G, DerSarkissian M, Duh MS, McGarry LJ, Kantarjian HM, Cortes JE. Overall survival with ponatinib versus allogeneic stem cell transplantation in Philadelphia chromosome-positive leukemias with the T315I mutation. Cancer. 2017 Aug 01; 123(15):2875-2880. PMID: 28387926.
    Citations: 1     Fields:    Translation:HumansCells
  44. DerSarkissian M, Bhak RH, Huang J, Buchs S, Vekeman F, Smolarz BG, Brett J, Ganguly R, Duh MS. Maintenance of weight loss or stability in subjects with obesity: a retrospective longitudinal analysis of a real-world population. Curr Med Res Opin. 2017 06; 33(6):1105-1110. PMID: 28294635.
    Citations: 2     Fields:    Translation:Humans
  45. Skarbnik AP, Ma E, Lafeuille MH, Fortier J, Feldman T, Duh MS, van de Velde H, Niculescu L, Bonthapally V, Goy A. Treatment patterns and outcomes with subcutaneous bortezomib in patients with relapsed mantle cell lymphoma: a retrospective, observational study of patient medical records from US community oncology practices. Leuk Lymphoma. 2017 08; 58(8):1968-1972. PMID: 28092998.
    Citations:    Fields:    Translation:Humans
  46. Kageleiry A, Samuelson D, Duh MS, Lefebvre P, Campbell J, Skotko BG. Out-of-pocket medical costs and third-party healthcare costs for children with Down syndrome. Am J Med Genet A. 2017 Mar; 173(3):627-637. PMID: 27966292.
    Citations:    Fields:    Translation:HumansPHPublic Health
  47. Lefebvre P, Duh MS, Lafeuille MH, Gozalo L, Desai U, Robitaille MN, Albers F, Yancey S, Ortega H, Forshag M, Lin X, Dalal AA. Burden of systemic glucocorticoid-related complications in severe asthma. Curr Med Res Opin. 2017 01; 33(1):57-65. PMID: 27627132.
    Citations: 3     Fields:    Translation:Humans
  48. Young-Xu Y, Duh MS, Muser E, DerSarkissian M, Faust E, Kageleiry A, Bhak RH, Fu DJ, Lefebvre P, Shiner B. Impact of Paliperidone Palmitate Versus Oral Atypical Antipsychotics on Health Care Resource Use and Costs in Veterans with Schizophrenia. J Clin Psychiatry. 2016 Oct; 77(10):e1332-e1341. PMID: 27574835.
    Citations: 2     Fields:    Translation:Humans
  49. Lafeuille MH, Frois C, Cloutier M, Duh MS, Lefebvre P, Pesa J, Clancy Z, Fastenau J, Durkin M. Factors Associated with Adherence to the HEDIS Quality Measure in Medicaid Patients with Schizophrenia. Am Health Drug Benefits. 2016 Oct; 9(7):399-410. PMID: 27994714.
    Citations: 1     
  50. DerSarkissian M, Xiao Y, Duh MS, Lefebvre P, Swensen AR, Bell CF. Comparing Clinical and Economic Outcomes Associated with Early Initiation of Combination Therapy of an Alpha Blocker and Dutasteride or Finasteride in Men with Benign Prostatic Hyperplasia in the United States. J Manag Care Spec Pharm. 2016 Oct; 22(10):1204-14. PMID: 27668569.
    Citations:    Fields:    Translation:Humans
  51. Duh MS, Cremieux P, Audenrode MV, Vekeman F, Karner P, Zhang H, Greenberg P. Can social media data lead to earlier detection of drug-related adverse events? Pharmacoepidemiol Drug Saf. 2016 12; 25(12):1425-1433. PMID: 27601271.
    Citations: 7     Fields:    Translation:Humans
  52. Law A, Pilon D, Lynen R, Laliberté F, Gozalo L, Lefebvre P, Duh MS. Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population. Reprod Health. 2016 Aug 22; 13(1):96. PMID: 27549429; PMCID: PMC4994322.
    Citations:    Fields:    Translation:Humans
  53. Ma E, Bonthapally V, Chawla A, Lefebvre P, Swords R, Lafeuille MH, Fortier J, Emond B, Duh MS, Dezube BJ. An Evaluation of Treatment Patterns and Outcomes in Elderly Patients Newly Diagnosed With Acute Myeloid Leukemia: A Retrospective Analysis of Electronic Medical Records From US Community Oncology Practices. Clin Lymphoma Myeloma Leuk. 2016 11; 16(11):625-636.e3. PMID: 27686689.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  54. Dalal AA, Duh MS, Gozalo L, Robitaille MN, Albers F, Yancey S, Ortega H, Forshag M, Lin X, Lefebvre P. Dose-Response Relationship Between Long-Term Systemic Corticosteroid Use and Related Complications in Patients with Severe Asthma. J Manag Care Spec Pharm. 2016 Jul; 22(7):833-47. PMID: 27348284.
    Citations: 3     Fields:    Translation:Humans
  55. Stanford RH, Nag A, Mapel DW, Lee TA, Rosiello R, Vekeman F, Gauthier-Loiselle M, Duh MS, Merrigan JF, Schatz M. Validation of a New Risk Measure for Chronic Obstructive Pulmonary Disease Exacerbation Using Health Insurance Claims Data. Ann Am Thorac Soc. 2016 07; 13(7):1067-75. PMID: 27070274.
    Citations:    Fields:    Translation:Humans
  56. Simon JA, Laliberté F, Duh MS, Pilon D, Kahler KH, Nyirady J, Davis PJ, Lefebvre P. Venous thromboembolism and cardiovascular disease complications in menopausal women using transdermal versus oral estrogen therapy. Menopause. 2016 06; 23(6):600-10. PMID: 26953655.
    Citations: 2     Fields:    Translation:Humans
  57. Lefebvre P, Pilon D, Robitaille MN, Lafeuille MH, Chow W, Pfeifer M, Duh MS. Real-world glycemic, blood pressure, and weight control in patients with type 2 diabetes mellitus treated with canagliflozin-an electronic health-record-based study. Curr Med Res Opin. 2016 06; 32(6):1151-9. PMID: 27115475.
    Citations: 2     Fields:    Translation:Humans
  58. Calnan M, Krishnarajah G, Duh MS, Haider BA, Yermakov S, Davis M, Yan S. Rotavirus vaccination in a Medicaid infant population from four US states: compliance, vaccination completion rate, and predictors of compliance. Hum Vaccin Immunother. 2016 05 03; 12(5):1235-43. PMID: 26900728; PMCID: PMC4963051.
    Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
  59. Quinlan SC, Cheng WY, Ishihara L, Irizarry MC, Holick CN, Duh MS. Development and validation of an algorithm for identifying urinary retention in a cohort of patients with epilepsy in a large US administrative claims database. Pharmacoepidemiol Drug Saf. 2016 Apr; 25(4):413-21. PMID: 26889887.
    Citations:    Fields:    Translation:Humans
  60. Xiao Y, Muser E, Fu DJ, Lafeuille MH, Pilon D, Emond B, Wu A, Duh MS, Lefebvre P. Comparison of Medicaid spending in schizoaffective patients treated with once monthly paliperidone palmitate or oral atypical antipsychotics. Curr Med Res Opin. 2016; 32(4):759-69. PMID: 26750639.
    Citations: 2     Fields:    Translation:Humans
  61. Krishnarajah G, Duh MS, Korves C, Demissie K. Public Health Impact of Complete and Incomplete Rotavirus Vaccination among Commercially and Medicaid Insured Children in the United States. PLoS One. 2016; 11(1):e0145977. PMID: 26751375.
    Citations:    Fields:    Translation:HumansCellsPHPublic Health
  62. Vekeman F, Sasane M, Cheng WY, Ramanakumar AV, Fortier J, Qiu Y, Duh MS, Paley C, Adams-Graves P. Adherence to iron chelation therapy and associated healthcare resource utilization and costs in Medicaid patients with sickle cell disease and thalassemia. J Med Econ. 2016; 19(3):292-303. PMID: 26618853.
    Citations: 5     Fields:    Translation:Humans
  63. Kruse G, Wong BJ, Duh MS, Lefebvre P, Lafeuille MH, Fastenau JM. Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment. Pharmacoeconomics. 2015 Oct; 33(10):1049-67. PMID: 25963579.
    Citations: 1     Fields:    Translation:Humans
  64. Lefebvre P, Duh MS, Lafeuille MH, Gozalo L, Desai U, Robitaille MN, Albers F, Yancey S, Ortega H, Forshag M, Lin X, Dalal AA. Acute and chronic systemic corticosteroid-related complications in patients with severe asthma. J Allergy Clin Immunol. 2015 Dec; 136(6):1488-1495. PMID: 26414880.
    Citations: 10     Fields:    Translation:Humans
  65. Vekeman F, Gauthier-Loiselle M, Faust E, Lefebvre P, Lahoz R, Duh MS, Sacco P. Patient and Caregiver Burden Associated With Fragile X Syndrome in the United States. Am J Intellect Dev Disabil. 2015 Sep; 120(5):444-59. PMID: 26322391.
    Citations: 1     Fields:    Translation:Humans
  66. Vekeman F, Magestro M, Karner P, Duh MS, Nichols T, van Waalwijk van Doorn-Khosrovani SB, Zonnenberg BA. Kidney involvement in tuberous sclerosis complex: the impact on healthcare resource use and costs. J Med Econ. 2015; 18(12):1060-70. PMID: 26201433.
    Citations: 5     Fields:    Translation:Humans
  67. Xiao Y, Muser E, Lafeuille MH, Pesa J, Fastenau J, Duh MS, Lefebvre P. Impact of paliperidone palmitate versus oral atypical antipsychotics on healthcare outcomes in schizophrenia patients. J Comp Eff Res. 2015 Nov; 4(6):579-92. PMID: 26168935.
    Citations: 4     Fields:    Translation:Humans
  68. Toy EL, Vekeman F, Lewis MC, Oglesby AK, Duh MS. Costs, resource utilization, and treatment patterns for patients with metastatic melanoma in a commercially insured setting. Curr Med Res Opin. 2015 Aug; 31(8):1561-72. PMID: 26086578.
    Citations: 6     Fields:    Translation:Humans
  69. Yermakov S, Davis M, Calnan M, Fay M, Cox-Buckley B, Sarda S, Duh MS, Iyer R. Impact of increasing adherence to disease-modifying therapies on healthcare resource utilization and direct medical and indirect work loss costs for patients with multiple sclerosis. J Med Econ. 2015; 18(9):711-20. PMID: 25903661.
    Citations: 4     Fields:    Translation:Humans
  70. Blinder MA, Duh MS, Sasane M, Trahey A, Paley C, Vekeman F. Age-Related Emergency Department Reliance in Patients with Sickle Cell Disease. J Emerg Med. 2015 Oct; 49(4):513-522.e1. PMID: 25910824.
    Citations: 4     Fields:    Translation:Humans
  71. Vekeman F, Cheng WY, Sasane M, Huynh L, Duh MS, Paley C, Mesa RA. Medical complications, resource utilization and costs in patients with myelofibrosis by frequency of blood transfusion and iron chelation therapy. Leuk Lymphoma. 2015; 56(10):2803-11. PMID: 25676036.
    Citations: 2     Fields:    Translation:Humans
  72. Wagner MJ, Amodu LI, Duh MS, Korves C, Solleza F, Manson SC, Diaz J, Neary MP, Demetri GD. A retrospective chart review of drug treatment patterns and clinical outcomes among patients with metastatic or recurrent soft tissue sarcoma refractory to one or more prior chemotherapy treatments. BMC Cancer. 2015 Mar 25; 15:175. PMID: 25885530; PMCID: PMC4397886.
    Citations: 6     Fields:    Translation:Humans
  73. Gradman AH, Vekeman F, Eldar-Lissai A, Trahey A, Duh MS, Ong SH. Response to comment on "is addition of vasodilators to loop diuretics of value in the care of hospitalized acute heart failure patients? Real-world evidence from a retrospective analysis of a large United States hospital database". J Card Fail. 2015 May; 21(5):435. PMID: 25796428.
    Citations:    Fields:    Translation:Humans
  74. Sarrel P, Portman D, Lefebvre P, Lafeuille MH, Grittner AM, Fortier J, Gravel J, Duh MS, Aupperle PM. Incremental direct and indirect costs of untreated vasomotor symptoms. Menopause. 2015 Mar; 22(3):260-6. PMID: 25714236.
    Citations: 4     Fields:    Translation:Humans
  75. Lafeuille MH, Grittner AM, Fortier J, Muser E, Fasteneau J, Duh MS, Lefebvre P. Comparison of rehospitalization rates and associated costs among patients with schizophrenia receiving paliperidone palmitate or oral antipsychotics. Am J Health Syst Pharm. 2015 Mar 01; 72(5):378-89. PMID: 25694413.
    Citations: 3     Fields:    Translation:Humans
  76. Yenikomshian MA, Guignard AP, Haguinet F, LaCasce AS, Skarin AT, Trahey A, Karner P, Duh MS. The epidemiology of herpes zoster and its complications in Medicare cancer patients. BMC Infect Dis. 2015 Feb 27; 15:106. PMID: 25888128; PMCID: PMC4352235.
    Citations: 2     Fields:    Translation:HumansCells
  77. Jordan L, Adams-Graves P, Kanter-Washko J, Oneal PA, Sasane M, Vekeman F, Bieri C, Magestro M, Marcellari A, Duh MS. Multicenter COMPACT study of COMplications in patients with sickle cell disease and utilization of iron chelation therapy. Curr Med Res Opin. 2015 Mar; 31(3):513-23. PMID: 25495135.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  78. Vekeman F, Cloutier M, Yermakov S, Amonkar MM, Arondekar B, Duh MS. Economic burden of brain metastases among patients with metastatic melanoma in a USA managed care population. Melanoma Res. 2014 Dec; 24(6):602-10. PMID: 24926818.
    Citations: 1     Fields:    Translation:Humans
  79. Lafeuille MH, Grittner AM, Gravel J, Bailey RA, Martin S, Garber L, Duh MS, Lefebvre P. Economic simulation of canagliflozin and sitagliptin treatment outcomes in patients with type 2 diabetes mellitus with inadequate glycemic control. J Med Econ. 2015 Feb; 18(2):113-25. PMID: 25350645.
    Citations:    Fields:    Translation:Humans
  80. Ayyagari R, Vekeman F, Lefebvre P, Ong SH, Faust E, Trahey A, Machnicki G, Duh MS. Pulse pressure and stroke risk: development and validation of a new stroke risk model. Curr Med Res Opin. 2014 Dec; 30(12):2453-60. PMID: 25265131.
    Citations: 3     Fields:    Translation:Humans
  81. Gradman AH, Vekeman F, Eldar-Lissai A, Trahey A, Ong SH, Duh MS. Is addition of vasodilators to loop diuretics of value in the care of hospitalized acute heart failure patients? Real-world evidence from a retrospective analysis of a large United States hospital database. J Card Fail. 2014 Nov; 20(11):853-63. PMID: 25152497.
    Citations:    Fields:    Translation:Humans
  82. Strosberg JR, Benson AB, Huynh L, Duh MS, Goldman J, Sahai V, Rademaker AW, Kulke MH. Clinical benefits of above-standard dose of octreotide LAR in patients with neuroendocrine tumors for control of carcinoid syndrome symptoms: a multicenter retrospective chart review study. Oncologist. 2014 Sep; 19(9):930-6. PMID: 25096997; PMCID: PMC4153451.
    Citations: 12     Fields:    Translation:HumansCTClinical Trials
  83. Porta C, Levy A, Hawkins R, Castellano D, Bellmunt J, Nathan P, McDermott R, Wagstaff J, Donnellan P, McCaffrey J, Vekeman F, Neary MP, Diaz J, Mehmud F, Duh MS. Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: a medical chart review across ten centers in five European countries. Cancer Med. 2014 Dec; 3(6):1517-26. PMID: 25045157; PMCID: PMC4298378.
    Citations: 9     Fields:    Translation:Humans
  84. Knopf KB, Duh MS, Lafeuille MH, Gravel J, Lefebvre P, Niculescu L, Ba-Mancini A, Ma E, Shi H, Comenzo RL. Meta-analysis of the efficacy and safety of bortezomib re-treatment in patients with multiple myeloma. Clin Lymphoma Myeloma Leuk. 2014 Oct; 14(5):380-8. PMID: 25023616.
    Citations: 9     Fields:    Translation:Humans
  85. Lafeuille MH, Dean J, Carter V, Duh MS, Fastenau J, Dirani R, Lefebvre P. Systematic review of long-acting injectables versus oral atypical antipsychotics on hospitalization in schizophrenia. Curr Med Res Opin. 2014 Aug; 30(8):1643-55. PMID: 24730586.
    Citations: 11     Fields:    Translation:Humans
  86. Athanasiou Y, Zavros M, Arsali M, Papazachariou L, Demosthenous P, Savva I, Voskarides K, Deltas C, Pierides A, Feriozzi S, Perrin A, West M, Nicholls K, Sunder-Plassmann G, Torras J, Neumann P, Cybulla M, Cofiell R, Kukreja A, Bedard K, Yan Y, Mickle A, Ogawa M, Bedrosian C, Faas S, Mészáros K, Pruess L, Gondan M, Ritz E, Schaefer F, Testa A, Spoto B, Leonardis D, Sanguedolce MC, Pisano A, Parlongo MR, Tripepi G, Mallamaci F, Zoccali C, Trujillano D, Bullich G, Ballarin J, Torra R, Estivill X, Ars E, Kleber ME, Delgado G, Grammer TB, Silbernagel G, Kraemer BK, Maerz W, Riccio E, Pisani A, Abdalla AA, Malone AF, Winn MP, Goodship T, Cronin C, Conlon PJ, Casserly LF, Nishio S, Sakuhara Y, Matsuoka N, Yamamoto J, Nakazawa D, Nakagakaki T, Abo D, Shibazaki S, Atsumi T, Mazzinghi B, Giglio S, Provenzano A, Becherucci F, Sansavini G, Ravaglia F, Roperto RM, Murer L, Lasagni L, Materassi M, Romagnani P, Schmidts M, Christou S, Cortes C, McInerney-Leo A, Kayserili H, Zankl A, Peter S, Duncan E, Wicking C, Beales PL, Mitchison H, Magestro M, Vekeman F, Nichols T, Karner P, Duh MS, Srivastava B, Van Doorn-Khosrovani SB, Zonnenberg BA, Musetti C, Quaglia M, Ghiggeri GM, Fogazzi GB, Settanni F, Boldorini RL, Lazzarich E, Airoldi A, Izzo C, Giordano M, Stratta P, Garrido P, Fernandes JC, Ribeiro S, Belo L, Costa EC, Reis F, Santos-Silva A, Youssef DM, Alshal AS, Salah K, Rashed AE, Kingswood JC, Jozwiak S, Belousova E, Frost M, Kuperman R, Bebin EM, Korf B, Flamini JR, Kohrman MH, Sparagana S, Wu JY, Berkowitz N, Miao S, Segal S, Ridolfi A, Bissler JJ, Franz DN, Oud MM, Van Bon BW, Bongers EM, Hoischen A, Marcelis CL, De Leeuw N, Mol SJ, Mortier G, Knoers NV, Brunner HG, Roepman R, Arts HH, Van Eerde AM, Van Der Zwaag B, Lilien MR, Renkema KY, De Borst MH, Van Haaften G, Giles RH, Navis GJ, Knoers NV, Lu KC, Su SL, Gigante M, Santangelo L, Diella S, Argentiero L, Cianciotta F, Martino M, Ranieri E, Grandaliano G, Giordano M, Gesualdo L, Fernandes J, Ribeiro S, Garrido P, Sereno J, Costa E, Reis F, Santos-Silva A, Chub O, Aires I, Polidori D, Santos AR, Brito Costa A, Simoes C, Rueff J, Nolasco F, Calado J, Van Der Tol L, Biegstraaten M, Florquin S, Vogt L, Van Den Bergh Weerman MA, Hollak CE, Hughes DA, Lachmann RH, Oliveira JP, Ortiz A, Svarstad E, Terryn W, Tøndel C, Waldek S, Wanner C, West ML, Linthorst GE, Kaesler N, Brandenburg V, Theuwissen E, Vermeer C, Floege J, Schlieper G, Krüger T, Xydakis D, Goulielmos G, Antonaki E, Stylianoy K, Sfakianaki M, Papadogiannakis A, Dafnis E, Mdimegh S, Ben Hadj Mbarek-Fredj I, Moussa A, Omezzine A, Zellama D, Mabrouk S, Zouari N, Hassayoun S, Chemli J, Achour A, Bouslama A, Abroug S, Spoto B, Leonardis D, Politi C, Pisano A, Cutrupi S, Testa A, Parlongo RM, D'Arrigo G, Tripepi G, Mallamaci F, Zoccali C, Mdimegh S, Ben Hadj Mbarek-Fredj I, Moussa A, Omezzine A, Mabrouk S, Zouari N, Hassayoun S, Chemli J, Zellama D, Achour A, Bouslama A, Abroug S, Hohenstein-Scheibenecker K, Schmidt A, Stylianou KG, Kyriazis J, Androvitsanea A, Tzanakakis M, Maragkaki E, Petrakis J, Stratakis S, Poulidaki R, Vardaki E, Petra C, Statigis S, Perakis K, Daphnis E, Cybulla M, West M, Nicholls K, Torras J, Neumann P, Sunder-Plassmann G, Feriozzi S, Metzinger-Le Meuth V, Taïbi F, M'Baya-Moutoula E, Louvet L, Massy Z, Metzinger L, Mani LY, Sidler D, Vogt B, Nikolskaya N, Cox JA, Kingswood JC, Smirnov A, Zarayski M, Kayukov I, Karunnaya H, Sipovski V, Kukoleva L, Dobronravov V. Genetic diseases and molecular genetics. Nephrol Dial Transplant. 2014 May; 29 Suppl 3:iii339-iii350. PMID: 24849976.
    Citations:    
  87. Victorson D, Carlozzi NE, Frank S, Beaumont JL, Cheng W, Gorin B, Duh MS, Samuelson D, Tulsky D, Gutierrez S, Nowinski CJ, Mueller A, Shen V, Sung V. Identifying Motor, Emotional-Behavioral, and Cognitive Deficits that Comprise the Triad of HD Symptoms from Patient, Caregiver, and Provider Perspectives. Tremor Other Hyperkinet Mov (N Y). 2014; 4:224. PMID: 24757585; PMCID: PMC3986490.
    Citations: 4     Fields:    
  88. Carlozzi NE, Victorson D, Sung V, Beaumont JL, Cheng W, Gorin B, Duh MS, Samuelson D, Tulsky D, Gutierrez S, Nowinski CJ, Mueller A, Shen V, Frank S. HD-PRO-TRIAD™ Validation: A Patient-reported Instrument for the Symptom Triad of Huntington's Disease. Tremor Other Hyperkinet Mov (N Y). 2014; 4:223. PMID: 24761312; PMCID: PMC3990832.
    Citations: 7     Fields:    
  89. Oglesby A, Korves C, Laliberté F, Dennis G, Rao S, Suthoff ED, Wei R, Duh MS. Impact of early versus late systemic lupus erythematosus diagnosis on clinical and economic outcomes. Appl Health Econ Health Policy. 2014 Apr; 12(2):179-90. PMID: 24573911.
    Citations: 8     Fields:    Translation:Humans
  90. Lafeuille MH, Dean J, Fastenau J, Panish J, Olson W, Markowitz M, Duh MS, Lefebvre P. Burden of schizophrenia on selected comorbidity costs. Expert Rev Pharmacoecon Outcomes Res. 2014 Apr; 14(2):259-67. PMID: 24593801.
    Citations: 2     Fields:    Translation:Humans
  91. Laliberté F, Lefebvre P, Law A, Duh MS, Pocoski J, Lynen R, Darney P. Medicaid spending on contraceptive coverage and pregnancy-related care. Reprod Health. 2014 Mar 03; 11(1):20. PMID: 24581033; PMCID: PMC3946128.
    Citations:    Fields:    Translation:Humans
  92. Duh MS, Hackshaw MD, Ivanova JI, Kruse G, Miller LA, Lefebvre P, Karner P, Wong B. Costs Associated with Intravenous Cancer Therapy Administration in Patients with Metastatic Soft Tissue Sarcoma in a US Population. Sarcoma. 2013; 2013:947413. PMID: 24453570; PMCID: PMC3884837.
    Citations:    
  93. Oh WK, McDermott D, Porta C, Levy A, Elaidi R, Scotte F, Hawkins R, Castellano D, Bellmunt J, Rha SY, Sun JM, Nathan P, Feinberg BA, Scott J, McDermott R, Ahn JH, Wagstaff J, Chang YH, Ou YC, Donnellan P, Huang CY, McCaffrey J, Chiang PH, Chuang CK, Korves C, Neary MP, Diaz JR, Mehmud F, Duh MS. Angiogenesis inhibitor therapies for advanced renal cell carcinoma: toxicity and treatment patterns in clinical practice from a global medical chart review. Int J Oncol. 2014 Jan; 44(1):5-16. PMID: 24247547; PMCID: PMC3867384.
    Citations: 8     Fields:    Translation:Humans
  94. Chu DS, Johnson SJ, Mallya UG, Davis MR, Sorg RA, Duh MS. Healthcare costs and utilization for privately insured patients treated for non-infectious uveitis in the USA. J Ophthalmic Inflamm Infect. 2013 Nov 06; 3(1):64. PMID: 24195808; PMCID: PMC3830557.
    Citations: 4     
  95. Huynh L, McCoy M, Law A, Tran KN, Knuth S, Lefebvre P, Sullivan S, Duh MS. Systematic literature review of the costs of pregnancy in the US. Pharmacoeconomics. 2013 Nov; 31(11):1005-30. PMID: 24158771.
    Citations: 4     Fields:    Translation:Humans
  96. Lefebvre P, Laliberté F, Nutescu EA, Duh MS, LaMori J, Bookhart BK, Olson WH, Dea K, Hossou Y, Schein J, Kaatz S. All-cause and disease-related health care costs associated with recurrent venous thromboembolism. Thromb Haemost. 2013 Dec; 110(6):1288-97. PMID: 24085327.
    Citations: 3     Fields:    Translation:Humans
  97. Lafeuille MH, Gravel J, Lefebvre P, Fastenau J, Muser E, Doshi D, Duh MS. Patterns of relapse and associated cost burden in schizophrenia patients receiving atypical antipsychotics. J Med Econ. 2013 Nov; 16(11):1290-9. PMID: 24006903.
    Citations: 7     Fields:    Translation:Humans
  98. Lafeuille MH, Laliberté-Auger F, Lefebvre P, Frois C, Fastenau J, Duh MS. Impact of atypical long-acting injectable versus oral antipsychotics on rehospitalization rates and emergency room visits among relapsed schizophrenia patients: a retrospective database analysis. BMC Psychiatry. 2013 Sep 10; 13:221. PMID: 24016390; PMCID: PMC3847215.
    Citations: 14     Fields:    Translation:Humans
  99. Virdi NS, Lefebvre P, Parisé H, Duh MS, Pilon D, Laliberté F, Sundaresan D, Garber L, Dirani R. Association of self-monitoring of blood glucose use on glycated hemoglobin and weight in newly diagnosed, insulin-naïve adult patients with type 2 diabetes. J Diabetes Sci Technol. 2013 Sep 01; 7(5):1229-42. PMID: 24124950; PMCID: PMC3876367.
    Citations: 2     Fields:    Translation:Humans
  100. Nakabayashi M, Hayes J, Taplin ME, Lefebvre P, Lafeuille MH, Pomerantz M, Sweeney C, Duh MS, Kantoff PW. Clinical predictors of survival in men with castration-resistant prostate cancer: evidence that Gleason score 6 cancer can evolve to lethal disease. Cancer. 2013 Aug 15; 119(16):2990-8. PMID: 23719969.
    Citations: 4     Fields:    Translation:Humans
  101. Parisé H, Laliberté F, Lefebvre P, Duh MS, Kim E, Agashivala N, Abouzaid S, Weinstock-Guttman B. Direct and indirect cost burden associated with multiple sclerosis relapses: excess costs of persons with MS and their spouse caregivers. J Neurol Sci. 2013 Jul 15; 330(1-2):71-7. PMID: 23647840.
    Citations: 6     Fields:    Translation:Humans
  102. Castellano D, Duh MS, Korves C, Suthoff ED, Neary M, Hernández Pastor LJ, Bellmunt J. Safety and treatment patterns of angiogenesis inhibitors in patients with advanced renal cell carcinoma in Spain. Expert Opin Drug Saf. 2013 Jul; 12(4):455-63. PMID: 23510293.
    Citations: 1     Fields:    Translation:Humans
  103. Blinder MA, Vekeman F, Sasane M, Trahey A, Paley C, Duh MS. Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs. Pediatr Blood Cancer. 2013 May; 60(5):828-35. PMID: 23335275.
    Citations: 12     Fields:    Translation:Humans
  104. Garrison LP, Wang ST, Huang H, Ba-Mancini A, Shi H, Chen K, Korves C, Dhawan R, Cakana A, van de Velde H, Corzo D, Duh MS. The cost-effectiveness of initial treatment of multiple myeloma in the U.S. with bortezomib plus melphalan and prednisone versus thalidomide plus melphalan and prednisone or lenalidomide plus melphalan and prednisone with continuous lenalidomide maintenance treatment. Oncologist. 2013; 18(1):27-36. PMID: 23299777; PMCID: PMC3556252.
    Citations: 18     Fields:    Translation:Humans
  105. Ivanova JI, Mytelka DS, Duh MS, Birnbaum HG, Cummings AK, San Roman AM, Price GL, Swindle RW. Evaluating the utility of existing patient-reported outcome scales in novel patient populations with pancreatic cancer, lung cancer, and myeloproliferative neoplasms using medicare current beneficiary survey data. Patient. 2013; 6(3):189-200. PMID: 23828691; PMCID: PMC3751268.
    Citations:    Fields:    Translation:Humans
  106. Laliberté F, Bookhart BK, Nelson WW, Lefebvre P, Schein JR, Rondeau-Leclaire J, Duh MS. Impact of once-daily versus twice-daily dosing frequency on adherence to chronic medications among patients with venous thromboembolism. Patient. 2013; 6(3):213-24. PMID: 23857628; PMCID: PMC3751276.
    Citations: 13     Fields:    Translation:Humans
  107. Gradman AH, Parisé H, Lefebvre P, Falvey H, Lafeuille MH, Duh MS. Initial combination therapy reduces the risk of cardiovascular events in hypertensive patients: a matched cohort study. Hypertension. 2013 Feb; 61(2):309-18. PMID: 23184383.
    Citations: 15     Fields:    Translation:Humans
  108. Manjunath R, Paradis PE, Parisé H, Lafeuille MH, Bowers B, Duh MS, Lefebvre P, Faught E. Burden of uncontrolled epilepsy in patients requiring an emergency room visit or hospitalization. Neurology. 2012 Oct 30; 79(18):1908-16. PMID: 23077014.
    Citations: 7     Fields:    Translation:Humans
  109. Laliberté F, Nelson WW, Lefebvre P, Schein JR, Rondeau-Leclaire J, Duh MS. Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients. Adv Ther. 2012 Aug; 29(8):675-90. PMID: 22898791.
    Citations: 22     Fields:    Translation:Humans
  110. Lefebvre P, Laliberté F, Nutescu EA, Duh MS, LaMori J, Bookhart BK, Olson WH, Dea K, Schein J, Kaatz S. All-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiaries. J Manag Care Pharm. 2012 Jun; 18(5):363-74. PMID: 22663169.
    Citations: 7     Fields:    Translation:Humans
  111. Lafeuille MH, Dean J, Zhang J, Duh MS, Gorsh B, Lefebvre P. Impact of omalizumab on emergency-department visits, hospitalizations, and corticosteroid use among patients with uncontrolled asthma. Ann Allergy Asthma Immunol. 2012 Jul; 109(1):59-64. PMID: 22727159.
    Citations: 6     Fields:    Translation:Humans
  112. Jensen JT, Lefebvre P, Laliberté F, Sarda SP, Law A, Pocoski J, Duh MS. Cost burden and treatment patterns associated with management of heavy menstrual bleeding. J Womens Health (Larchmt). 2012 May; 21(5):539-47. PMID: 22360696.
    Citations: 8     Fields:    Translation:Humans
  113. Lafeuille MH, Vekeman F, Wang ST, Kerrigan M, Menditto L, Duh MS. Lifetime costs to Medicare of providing care to patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2012 Jun; 53(6):1146-54. PMID: 22111902.
    Citations: 3     Fields:    Translation:Humans
  114. Helmers SL, Duh MS, Guérin A, Sarda SP, Samuelson TM, Bunker MT, Olin BD, Jackson SD, Faught E. Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy. Eur J Paediatr Neurol. 2012 Sep; 16(5):449-58. PMID: 22261080.
    Citations: 10     Fields:    Translation:Humans
  115. Lafeuille MH, Duh MS, Zhang J, Wertz D, Gu T, Swensen A, Lefebvre P. Concomitant asthma medication use in patients receiving omalizumab: results from three large insurance claims databases. J Asthma. 2011 Nov; 48(9):923-30. PMID: 21978232.
    Citations:    Fields:    Translation:Humans
  116. Laliberté F, Dea K, Duh MS, Kahler KH, Rolli M, Lefebvre P. Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy. Menopause. 2011 Oct; 18(10):1052-9. PMID: 21775912.
    Citations: 13     Fields:    Translation:Humans
  117. Helmers SL, Duh MS, Guérin A, Sarda SP, Samuelson TM, Bunker MT, Olin BD, Jackson SD, Faught E. Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsy. Epilepsy Behav. 2011 Oct; 22(2):370-5. PMID: 21872534.
    Citations: 5     Fields:    Translation:Humans
  118. Vekeman F, LaMori JC, Laliberté F, Nutescu E, Duh MS, Bookhart BK, Schein J, Dea K, Olson WH, Lefebvre P. Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population. J Med Econ. 2011; 14(3):324-34. PMID: 21506632.
    Citations: 6     Fields:    Translation:Humans
  119. Feinberg BA, Jolly P, Wang ST, Fortner B, Scott J, Gilmore J, Neary MP, Duh MS. Safety and treatment patterns of angiogenesis inhibitors in patients with metastatic renal cell carcinoma: evidence from US community oncology clinics. Med Oncol. 2012 Jun; 29(2):786-94. PMID: 21479699.
    Citations: 7     Fields:    Translation:Humans
  120. Porta C, Paglino C, Imarisio I, Canipari C, Chen K, Neary M, Duh MS. Safety and treatment patterns of multikinase inhibitors in patients with metastatic renal cell carcinoma at a tertiary oncology center in Italy. BMC Cancer. 2011 Mar 24; 11:105. PMID: 21435216; PMCID: PMC3079688.
    Citations: 11     Fields:    Translation:Humans
  121. Mease PJ, Zimetbaum PJ, Duh MS, Vekeman F, Guérin A, Boerstoel-Streefland M, Jiang W, Lefebvre P. Epidemiologic Evaluation of Cardiovascular Risk in Patients Receiving Milnacipran, Venlafaxine, or Amitriptyline: Evidence from French Health Data. Ann Pharmacother. 2011 Feb; 45(2):179-88. PMID: 21304035.
    Citations: 1     Fields:    Translation:Humans
  122. Scharre DW, Vekeman F, Lefebvre P, Mody-Patel N, Kahler KH, Duh MS. Use of antipsychotic drugs in patients with Alzheimer's disease treated with rivastigmine versus donepezil: a retrospective, parallel-cohort, hypothesis-generating study. Drugs Aging. 2010 Nov 01; 27(11):903-13. PMID: 20964464.
    Citations: 1     Fields:    Translation:Humans
  123. Duh MS, Vekeman F, Korves C, Lefebvre P, Dial E, Latremouille-Viau D, Wei RS, Stangle BE, Lafeuille MH, Michna E, Greenberg PE. Risk of hepatotoxicity-related hospitalizations among patients treated with opioid/acetaminophen combination prescription pain medications. Pain Med. 2010 Nov; 11(11):1718-25. PMID: 21044262.
    Citations: 1     Fields:    Translation:Humans
  124. Toy EL, Beaulieu NU, McHale JM, Welland TR, Plauschinat CA, Swensen A, Duh MS. Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs. Respir Med. 2011 Mar; 105(3):435-41. PMID: 20880687.
    Citations: 48     Fields:    Translation:Humans
  125. Helmers SL, Paradis PE, Manjunath R, Duh MS, Lafeuille MH, Latrémouille-Viau D, Lefebvre P, Labiner DM. Economic burden associated with the use of generic antiepileptic drugs in the United States. Epilepsy Behav. 2010 Aug; 18(4):437-44. PMID: 20580619.
    Citations: 6     Fields:    Translation:Humans
  126. Toy EL, Gallagher KF, Stanley EL, Swensen AR, Duh MS. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review. COPD. 2010 Jun; 7(3):214-28. PMID: 20486821.
    Citations: 49     Fields:    Translation:Humans
  127. Michna E, Duh MS, Korves C, Dahl JL. Removal of opioid/acetaminophen combination prescription pain medications: assessing the evidence for hepatotoxicity and consequences of removal of these medications. Pain Med. 2010 Mar; 11(3):369-78. PMID: 20447306.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  128. Sethi NK, Torgovnick J, Sethi PK, Arsura E, Emmanuel Paradis P, Duh MS, Durkin MB, Wan GJ. The risks and costs of multiple-generic substitution of topiramate. Neurology. 2010 Feb 23; 74(8):701-2; author reply 701-2. PMID: 20177127.
    Citations: 1     Fields:    Translation:Humans
  129. Weide R, Koppler H, Antras L, Smith M, Chang MP, Green J, Wintfeld N, Neary MP, Duh MS. Renal toxicity in patients with multiple myeloma receiving zoledronic acid vs. ibandronate: a retrospective medical records review. J Cancer Res Ther. 2010 Jan-Mar; 6(1):31-5. PMID: 20479544.
    Citations: 2     Fields:    Translation:Humans
  130. Duh MS, Fulcher NM, White LA, Jayawant SS, Ramamurthy P, Moyneur E, Ong SH. Costs associated with cardiovascular events in patients with hypertension in US managed care settings. J Am Soc Hypertens. 2009 Nov-Dec; 3(6):403-15. PMID: 20409983.
    Citations: 6     Fields:    
  131. Choueiri TK, Duh MS, Clement J, Brick AJ, Rogers MJ, Kwabi C, Shah K, Percy AG, Antràs L, Jayawant SS, Chen K, Wang ST, Luka A, Neary MP, McDermott D, Oh WK. Angiogenesis inhibitor therapies for metastatic renal cell carcinoma: effectiveness, safety and treatment patterns in clinical practice-based on medical chart review. BJU Int. 2010 May; 105(9):1247-54. PMID: 19863525.
    Citations: 21     Fields:    Translation:Humans
  132. Heaney ML, Toy EL, Vekeman F, Laliberté F, Dority BL, Perlman D, Barghout V, Duh MS. Comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy-induced neutropenia. Cancer. 2009 Oct 15; 115(20):4839-48. PMID: 19637341.
    Citations: 13     Fields:    Translation:Humans
  133. Duh MS, Cahill KE, Paradis PE, Cremieux PY, Greenberg PE. The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence. Expert Opin Pharmacother. 2009 Oct; 10(14):2317-28. PMID: 19663636.
    Citations: 8     Fields:    Translation:Humans
  134. Duh MS, Gosselin A, Luo R, Lohoues H, Lewis BE, Crawley JA. Impact of compliance with proton pump inhibitors on NSAID treatment. Am J Manag Care. 2009 Oct; 15(10):681-8. PMID: 19845420.
    Citations: 2     Fields:    Translation:Humans
  135. Raptis A, Duh MS, Wang ST, Dial E, Fanourgiakis I, Fortner B, Paley C, Mody-Patel N, Corral M, Scott J. Treatment of transfusional iron overload in patients with myelodysplastic syndrome or severe anemia: data from multicenter clinical practices. Transfusion. 2010 Jan; 50(1):190-9. PMID: 19719471.
    Citations: 8     Fields:    Translation:Humans
  136. Duh MS, Dial E, Choueiri TK, Fournier AA, Antras L, Rodermund D, Neary MP, Oh WK. Cost implications of IV versus oral anti-angiogenesis therapies in patients with advanced renal cell carcinoma: retrospective claims database analysis. Curr Med Res Opin. 2009 Aug; 25(8):2081-90. PMID: 19586325.
    Citations: 4     Fields:    Translation:Humans
  137. Paradis PE, Latrémouille-Viau D, Moore Y, Mishagina N, Lafeuille MH, Lefebvre P, Gaudig M, Duh MS. Projected economic impact of clinical findings of generic entry of topiramate on G4 European countries. Curr Med Res Opin. 2009 Jul; 25(7):1793-805. PMID: 19505202.
    Citations: 4     Fields:    Translation:Humans
  138. Laliberté F, Bookhart BK, Vekeman F, Corral M, Duh MS, Bailey RA, Piech CT, Lefebvre P. Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective. J Manag Care Pharm. 2009 May; 15(4):312-22. PMID: 19422271.
    Citations: 26     Fields:    Translation:Humans
  139. Vekeman F, McKenzie RS, Bookhart BK, Laliberté F, Duh MS, Tak Piech C, Lefebvre P. Drug utilisation and cost considerations of erythropoiesis stimulating agents in oncology patients receiving chemotherapy: observations from a large managed-care database. J Med Econ. 2009 Mar; 12(1):1-8. PMID: 19450059.
    Citations: 2     Fields:    Translation:Humans
  140. Vekeman F, Bookhart BK, White J, McKenzie RS, Duh MS, Piech CT, Lefebvre P. Impact of limiting erythropoiesis-stimulating agent use for chemotherapy-induced anemia on the United States blood supply margin. Transfusion. 2009 May; 49(5):895-902. PMID: 19175548.
    Citations: 4     Fields:    Translation:Humans
  141. Diel IJ, Weide R, Köppler H, Antràs L, Smith M, Green J, Wintfeld N, Neary M, Duh MS. Risk of renal impairment after treatment with ibandronate versus zoledronic acid: a retrospective medical records review. Support Care Cancer. 2009 Jun; 17(6):719-25. PMID: 19089462.
    Citations: 9     Fields:    Translation:Humans
  142. Fowler JF, Duh MS, Rovba L, Buteau S, Pinheiro L, Lobo F, Sung J, Doyle JJ, Swensen A, Mallett DA, Kosicki G. The impact of psoriasis on health care costs and patient work loss. J Am Acad Dermatol. 2008 Nov; 59(5):772-80. PMID: 19119095.
    Citations: 18     Fields:    Translation:Humans
  143. Faught RE, Weiner JR, Guérin A, Cunnington MC, Duh MS. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study. Epilepsia. 2009 Mar; 50(3):501-9. PMID: 19183224.
    Citations: 24     Fields:    Translation:Humans
  144. Chen L, Antras L, Duh MS, Neary M, O'Brien ME. Symptom assessment in relapsed small cell lung cancer: cross-validation of the patient symptom assessment in lung cancer instrument. J Thorac Oncol. 2008 Oct; 3(10):1137-45. PMID: 18827610.
    Citations: 1     Fields:    Translation:Humans
  145. Gosselin A, Luo R, Lohoues H, Toy E, Lewis B, Crawley J, Duh MS. The impact of proton pump inhibitor compliance on health-care resource utilization and costs in patients with gastroesophageal reflux disease. Value Health. 2009 Jan-Feb; 12(1):34-9. PMID: 19895371.
    Citations: 6     Fields:    Translation:Humans
  146. Weiner JR, Toy EL, Sacco P, Duh MS. Costs, quality of life and treatment compliance associated with antibiotic therapies in patients with cystic fibrosis: a review of the literature. Expert Opin Pharmacother. 2008 Apr; 9(5):751-66. PMID: 18345953.
    Citations: 5     Fields:    Translation:Humans
  147. Moyo V, Lefebvre P, Duh MS, Yektashenas B, Mundle S. Erythropoiesis-stimulating agents in the treatment of anemia in myelodysplastic syndromes: a meta-analysis. Ann Hematol. 2008 Jul; 87(7):527-36. PMID: 18351340.
    Citations: 21     Fields:    Translation:Humans
  148. LeLorier J, Duh MS, Paradis PE, Latrémouille-Viau D, Lefebvre P, Manjunath R, Sheehy O. Economic impact of generic substitution of lamotrigine: projected costs in the US using findings in a Canadian setting. Curr Med Res Opin. 2008 Apr; 24(4):1069-81. PMID: 18315941.
    Citations: 6     Fields:    Translation:Humans
  149. Duh MS, Reynolds Weiner J, Lefebvre P, Neary M, Skarin AT. Costs associated with intravenous chemotherapy administration in patients with small cell lung cancer: a retrospective claims database analysis. Curr Med Res Opin. 2008 Apr; 24(4):967-74. PMID: 18282373.
    Citations: 6     Fields:    Translation:Humans
  150. Moyneur E, Bookhart BK, Mody SH, Fournier AA, Mallett D, Duh MS. The economic impact of pre-dialysis epoetin alpha on health care and work loss costs in chronic kidney disease: an employer's perspective. Dis Manag. 2008 Feb; 11(1):49-58. PMID: 18279115.
    Citations: 1     Fields:    Translation:Humans
  151. Sikand H, Decter A, Greco T, Watson SH, Kang YJ, Mody SH, Piech CT, Duh MS, Naeem A. Cost analytic model to determine the least costly inpatient erythropoiesis stimulating therapy regimen. Ann Pharmacother. 2008 Jan; 42(1):16-23. PMID: 18029428.
    Citations:    Fields:    Translation:Humans
  152. Duh MS, Weiner JR, White LA, Lefebvre P, Greenberg PE. Management of anaemia: a critical and systematic review of the cost effectiveness of erythropoiesis-stimulating agents. Pharmacoeconomics. 2008; 26(2):99-120. PMID: 18198931.
    Citations: 5     Fields:    Translation:HumansAnimals
  153. Duh MS, Mody SH, Lefebvre P, Woodman RC, Buteau S, Piech CT. Anaemia and the risk of injurious falls in a community-dwelling elderly population. Drugs Aging. 2008; 25(4):325-34. PMID: 18361542.
    Citations: 9     Fields:    Translation:Humans
  154. Chen L, Antras L, Duh MS, Levy N, Neary M, O'Brien ME, von Pawel J. Psychometric validation of the Patient Symptom Assessment in Lung Cancer instrument for small cell lung cancer. Curr Med Res Opin. 2007 Nov; 23(11):2741-52. PMID: 17900394.
    Citations: 1     Fields:    Translation:Humans
  155. Fowler JF, Duh MS, Rovba L, Buteau S, Pinheiro L, Lobo F, Sung J, Doyle JJ, Swensen A, Mallett DA, Kosicki G. The direct and indirect cost burden of atopic dermatitis: an employer-payer perspective. Manag Care Interface. 2007 Oct; 20(10):26-32. PMID: 18405204.
    Citations: 4     Fields:    Translation:Humans
  156. Vekeman F, McKenzie RS, Lefebvre P, Watson SH, Mody SH, Piech CT, Duh MS. Dose and cost comparison of erythropoietic agents in the inpatient hospital setting. Am J Health Syst Pharm. 2007 Sep 15; 64(18):1943-9. PMID: 17823106.
    Citations: 2     Fields:    Translation:Humans
  157. Duh MS, Andermann F, Paradis PE, Weiner J, Manjunath R, Crémieux PY. The economic consequences of generic substitution for antiepileptic drugs in a public payer setting: the case of lamotrigine. Dis Manag. 2007 Aug; 10(4):216-25. PMID: 17718660.
    Citations: 6     Fields:    Translation:Humans
  158. Wu WK, Duh MS, Lefebvre P. Is there a difference in the cost-effectiveness of erythropoietic therapies for the treatment of anemia in patients receiving HCV combination therapy? Hepatology. 2007 Jul; 46(1):283; author reply 283-4. PMID: 17596889.
    Citations:    Fields:    Translation:Humans
  159. Oh WK, Proctor K, Nakabayashi M, Evan C, Tormey LK, Daskivich T, Antràs L, Smith M, Neary MP, Duh MS. The risk of renal impairment in hormone-refractory prostate cancer patients with bone metastases treated with zoledronic acid. Cancer. 2007 Mar 15; 109(6):1090-6. PMID: 17311345.
    Citations: 8     Fields:    Translation:Humans
  160. Andermann F, Duh MS, Gosselin A, Paradis PE. Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes. Epilepsia. 2007 Mar; 48(3):464-9. PMID: 17346246.
    Citations: 46     Fields:    Translation:Humans
  161. Lefebvre P, Duh MS, Mody SH, Bookhart B, Piech CT. The economic impact of epoetin alfa therapy on delaying time to dialysis in elderly patients with chronic kidney disease. Dis Manag. 2007 Feb; 10(1):37-45. PMID: 17309363.
    Citations: 3     Fields:    Translation:Humans
  162. Zilberberg MD, Carter C, Lefebvre P, Raut M, Vekeman F, Duh MS, Shorr AF. Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study. Crit Care. 2007; 11(3):R63. PMID: 17553147; PMCID: PMC2206425.
    Citations: 22     Fields:    Translation:Humans
  163. Lefebvre P, Duh MS, Buteau S, Bookhart B, Mody SH. Medical costs of untreated anemia in elderly patients with predialysis chronic kidney disease. J Am Soc Nephrol. 2006 Dec; 17(12):3497-502. PMID: 17082245.
    Citations: 5     Fields:    Translation:Humans
  164. Duh MS, Latypova A, Greenberg P. Impact and treatment of anemia in the elderly: clinical, epidemiological and economic perspectives. Expert Rev Pharmacoecon Outcomes Res. 2006 Oct; 6(5):577-90. PMID: 20528504.
    Citations: 3     Fields:    
  165. Lefebvre P, Gosselin A, McKenzie RS, Mody SH, Piech CT, Duh MS. Dosing patterns, treatment costs, and frequency of physician visits in adults with cancer receiving erythropoietic agents in managed care organizations. Curr Med Res Opin. 2006 Sep; 22(9):1623-31. PMID: 16968565.
    Citations: 3     Fields:    Translation:Humans
  166. Duh MS, Mody SH, Scott McKenzie R, Lefebvre P, Gosselin A, Tak Piech C. Dosing patterns and costs of erythropoietic agents in patients with chronic kidney disease not on dialysis in managed care organizations. Clin Ther. 2006 Sep; 28(9):1443-50. PMID: 17062316.
    Citations: 1     Fields:    Translation:Humans
  167. Clancy TE, Sengupta TP, Paulus J, Ahmed F, Duh MS, Kulke MH. Alkaline phosphatase predicts survival in patients with metastatic neuroendocrine tumors. Dig Dis Sci. 2006 May; 51(5):877-84. PMID: 16758309.
    Citations: 17     Fields:    Translation:Humans
  168. Mincey BA, Duh MS, Thomas SK, Moyneur E, Marynchencko M, Boyce SP, Mallett D, Perez EA. Risk of cancer treatment-associated bone loss and fractures among women with breast cancer receiving aromatase inhibitors. Clin Breast Cancer. 2006 Jun; 7(2):127-32. PMID: 16800971.
    Citations: 31     Fields:    Translation:Humans
  169. Fowler JF, Duh MS, Chang J, Person J, Thorn D, Raut M, Ghosh A, Den E, Emani S. A survey-based assessment of the prevalence and severity of chronic hand dermatitis in a managed care organization. Cutis. 2006 Jun; 77(6):385-92. PMID: 16838772.
    Citations: 2     Fields:    Translation:Humans
  170. Fowler JF, Ghosh A, Sung J, Emani S, Chang J, Den E, Thorn D, Person J, Duh MS. Impact of chronic hand dermatitis on quality of life, work productivity, activity impairment, and medical costs. J Am Acad Dermatol. 2006 Mar; 54(3):448-57. PMID: 16488296.
    Citations: 6     Fields:    Translation:Humans
  171. Duh MS, Mody SH, McKenzie RS, Lefebvre P, Gosselin A, Bookhart BK, Piech CT. Dosing patterns and treatment costs of erythropoietic agents in elderly patients with pre-dialysis chronic kidney disease in managed care organisations. Drugs Aging. 2006; 23(12):969-76. PMID: 17154661.
    Citations: 3     Fields:    Translation:Humans
  172. Sands BE, Duh MS, Cali C, Ajene A, Bohn RL, Miller D, Cole JA, Cook SF, Walker AM. Algorithms to identify colonic ischemia, complications of constipation and irritable bowel syndrome in medical claims data: development and validation. Pharmacoepidemiol Drug Saf. 2006 Jan; 15(1):47-56. PMID: 15915441.
    Citations: 9     Fields:    Translation:Humans
  173. Smith MR, Boyce SP, Moyneur E, Duh MS, Raut MK, Brandman J. Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer. J Urol. 2006 Jan; 175(1):136-9; discussion 139. PMID: 16406890.
    Citations: 57     Fields:    Translation:Humans
  174. Campos SM, Duh MS, Lefebvre P, Rosberg J. Benefits associated with an early hemoglobin response to epoetin alfa therapy in the treatment of chemotherapy-related anemia. J Natl Compr Canc Netw. 2005 Nov; 3(6):807-16. PMID: 16316616.
    Citations: 3     Fields:    Translation:Humans
  175. Duh MS, L Mark T. Cost-effectiveness of epoetin alfa and darbepoetin alfa in patients with chemotherapy-related anemia. Expert Rev Pharmacoecon Outcomes Res. 2005 Aug; 5(4):383-94. PMID: 19807257.
    Citations: 1     Fields:    
  176. Duh MS, Lefebvre P, Fastenau J, Piech CT, Waltzman RJ. Assessing the clinical benefits of erythropoietic agents using area under the hemoglobin change curve. Oncologist. 2005 Jun-Jul; 10(6):438-48. PMID: 15967837.
    Citations: 6     Fields:    Translation:Humans
  177. Shorr AF, Duh MS, Kelly KM, Kollef MH. Red blood cell transfusion and ventilator-associated pneumonia: A potential link? Crit Care Med. 2004 Mar; 32(3):666-74. PMID: 15090945.
    Citations: 22     Fields:    Translation:Humans
  178. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, MacIntyre NR, Shabot MM, Duh MS, Shapiro MJ. The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States. Crit Care Med. 2004 Jan; 32(1):39-52. PMID: 14707558.
    Citations: 198     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Duh's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (500)
Explore
_
Co-Authors (21)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.